Physician profile
Meghan Crawley
NPI 1770993974
$5,438.25
in general payments reported to CMS, 2019-2025
15 companies · $307 in 2025
The $307 reported for 2025 was more than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,227 · 2021: $192 · 2022: $96.85 · 2023: $3,340 · 2024: $276 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Food and Beverage: $809 · Travel and Lodging: $614.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Food and Beverage | $808.76 |
| Travel and Lodging | $614.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,431.37 | 2019-2023 | Da Vinci Sp, Da Vinci Surgical System |
| Stryker Corporation | $875.68 | 2019 | |
| Depuy Synthes Sales INC. | $254.40 | 2024-2025 | Na, Matrixmandible |
| Inspire Medical Systems, INC. | $165.67 | 2023 | Inspire |
| Acera Surgical, INC. | $148.63 | 2025 | Restrata Wound Matrix |
| Genzyme Corporation | $124.80 | 2021 | |
| Bolder Surgical, LLC | $96.85 | 2022 | |
| Kls-Martin L.P. | $93.15 | 2025 | |
| Phadia US INC. | $50.98 | 2019 | |
| Atos Medical INC | $50.00 | 2021 | |
| Axogen | $42.44 | 2024 | Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap, Axoguard Nerve Protector |
| Checkpoint Surgical, INC | $39.42 | 2021-2023 | Checkpoint Stimulators |
| Integra Lifesciences Corporation | $29.81 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Aroa Biosurgery Incorporated | $19.86 | 2023 | |
| Lilly USA, LLC | $15.19 | 2024 | Retevmo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meghan Crawley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.